Glaucoma 360: Accessible glaucoma care in 1 second (BELKIN Laser)

July 12, 2020

Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).

COVID-19: Smart thermometer shows real-time changes in fever levels

July 11, 2020

Amid the COVID-19 pandemic, a smart thermometer has become a valuable tool in detecting coronavirus hotspots.

COVID-19 mutations: A more efficient virus

July 10, 2020

While the spikes that are characteristic of COVID-19 are well-documented, researchers have detected a subtle change from the onset of the pandemic in January to May, when the virus ultimately engulfed New York City.

New molecule for allergic conjunctivitis makes debut

July 10, 2020

First new therapy in nearly a decade offers another option for physicians, patients

Glaucoma 360: Apps for the visually challenged

July 09, 2020

ICYMI: Yvonne Ou, MD, discusses her presentation on "Apps for the visually challenged," during the 2020 Glaucoma 360 annual meeting in San Francisco, California.

Company seeks first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications

July 08, 2020

Patient enrollment for the NORSE 2 clinical trial has been completed, with safety and efficacy data expected to be reported in the third quarter of 2021.

Study targets topical medication adherence, visual field progression

July 08, 2020

Research is seeking benefits, options for open-angle glaucoma patients

Strategies for coping with physician depression during COVID-19

July 07, 2020

Medical practitioners face emotional burden, other hurdles from pandemic

Glaucoma 360: Risk factors for glaucoma progression

July 07, 2020

Dale Heuer, MD discusses the importance of ophthalmologists identifying and providing more aggressive treatment care for patients with low/high risks of developing glaucoma.

x